Nuveen Asset Management, LLC Cor Medix Inc. Transaction History

Nuveen Asset Management, LLC

$334 Billion
Q2 2024

A detailed history of Nuveen Asset Management, LLC transactions in Cor Medix Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 170,299 shares of CRMD stock, worth $1.37 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

170,299

Previous 149,680 13.78%

Holding current value

$1.37 Million

Previous $634,000 16.25%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$4.08 - $6.39 $84,125 - $131,755	20,619 Added 13.78%	170,299 $737,000
Q1 2024 May 13, 2024	SELL	$2.94 - $4.24 $269,894 - $389,236	-91,801 Reduced 38.02%	149,680 $634,000
Q4 2023 Feb 14, 2024	BUY	$3.0 - $4.01 $253,968 - $339,470	84,656 Added 53.98%	241,481 $907,000
Q3 2023 Nov 14, 2023	SELL	$3.6 - $4.46 $144,756 - $179,336	-40,210 Reduced 20.41%	156,825 $580,000
Q2 2023 Aug 14, 2023	BUY	$3.94 - $5.8 $776,317 - $1.14 Million	197,035 New	197,035 $780,000
Q2 2022 Aug 15, 2022	SELL	$2.73 - $5.61 $485,735 - $998,159	-177,925 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$3.83 - $6.24 $5,090 - $8,292	1,329 Added 0.75%	177,925 $880,000
Q4 2021 Feb 14, 2022	SELL	$4.47 - $5.56 $103,051 - $128,180	-23,054 Reduced 11.55%	176,596 $850,000
Q3 2021 Nov 12, 2021	SELL	$4.46 - $7.11 $119,594 - $190,654	-26,815 Reduced 11.84%	199,650 $932,000
Q2 2021 Aug 16, 2021	BUY	$6.05 - $10.09 $176,908 - $295,041	29,241 Added 14.83%	226,465 $1.55 Million
Q1 2021 May 17, 2021	SELL	$6.84 - $17.58 $114,508 - $294,306	-16,741 Reduced 7.82%	197,224 $1.97 Million
Q4 2020 Feb 16, 2021	BUY	$5.0 - $9.15 $401,285 - $734,351	80,257 Added 60.02%	213,965 $1.59 Million
Q3 2020 Nov 16, 2020	BUY	$3.96 - $6.15 $46,696 - $72,520	11,792 Added 9.67%	133,708 $806,000
Q2 2020 Aug 14, 2020	SELL	$3.08 - $6.56 $203,307 - $433,019	-66,009 Reduced 35.13%	121,916 $768,000
Q1 2020 May 14, 2020	BUY	$2.35 - $7.08 $61,866 - $186,388	26,326 Added 16.29%	187,925 $674,000
Q4 2019 Feb 14, 2020	BUY	$4.96 - $7.75 $496,783 - $776,224	100,158 Added 163.01%	161,599 $1.18 Million
Q3 2019 Nov 14, 2019	SELL	$6.38 - $9.69 $670,538 - $1.02 Million	-105,100 Reduced 63.11%	61,441 $392,000
Q2 2019 Aug 15, 2019	BUY	$5.93 - $10.57 $987,588 - $1.76 Million	166,541 New	166,541 $1.49 Million

Others Institutions Holding CRMD

# of Institutions

101

Shares Held

16.9M

Call Options Held

70.5K

Put Options Held

358K

View Full List

About CorMedix Inc.

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $332M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

More about CRMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Cor Medix Inc. Transaction History